Select Medical Holdings Corporation (NYSE:SEM – Get Free Report) has received a consensus recommendation of “Hold” from the seven analysts that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $15.50.
A number of research analysts have commented on the stock. Weiss Ratings upgraded shares of Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, June 4th. Zacks Research raised shares of Select Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Finally, Mizuho reaffirmed a “neutral” rating and set a $16.50 target price (down from $17.00) on shares of Select Medical in a report on Tuesday, May 12th.
Read Our Latest Stock Analysis on Select Medical
Institutional Investors Weigh In On Select Medical
Select Medical Stock Performance
Shares of SEM stock opened at $16.51 on Friday. The business has a 50-day moving average price of $16.52 and a two-hundred day moving average price of $16.02. Select Medical has a 12-month low of $11.65 and a 12-month high of $16.99. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.88. The firm has a market cap of $2.05 billion, a P/E ratio of 15.58, a price-to-earnings-growth ratio of 0.95 and a beta of 1.01.
Select Medical (NYSE:SEM – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.07). The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. Select Medical had a net margin of 2.42% and a return on equity of 6.62%. Select Medical’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.44 earnings per share. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Equities analysts anticipate that Select Medical will post 1.26 EPS for the current fiscal year.
Select Medical Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 28th. Stockholders of record on Thursday, May 14th were paid a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date of this dividend was Thursday, May 14th. Select Medical’s dividend payout ratio (DPR) is 23.58%.
About Select Medical
Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.
Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.
Read More
- Five stocks we like better than Select Medical
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.
